EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial

Premranjan Kumar, Chun Liu, James Suliburk, Jean W Hsu, Raja Muthupillai, Farook Jahoor, Charles G Minard, George E Taffet, Rajagopal V Sekhar iD

The Journals of Gerontology: Series A · 26.01.2023 · 78 (1) · 75-89

DOI: 10.1093/gerona/glac135 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journals of Gerontology: Series A, online erschienen am 17.08.2022. Verfasst von Premranjan Kumar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Metabolism Unit, Section of Endocrinology, Diabetes and Metabolism, Department of Medicine. Hauptthemen laut MEDLINE: Acetylcysteine, Insulin Resistance. Die Arbeit wurde bisher 158-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institutes of Health, National Institute of Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elevated oxidative stress (OxS), mitochondrial dysfunction, and hallmarks of aging are identified as key contributors to aging, but improving/reversing these defects in older adults (OA) is challenging. In prior studies, we identified that deficiency of the intracellular antioxidant glutathione (GSH) could play a role and reported that supplementing GlyNAC (combination of glycine and N-acetylcysteine [NAC]) in aged mice improved GSH deficiency, OxS, mitochondrial fatty-acid oxidation (MFO), and insulin resistance (IR). To test whether GlyNAC supplementation in OA could improve GSH deficiency, OxS, mitochondrial dysfunction, IR, physical function, and aging hallmarks, we conducted a placebo-controlled randomized clinical trial.

Methods

Twenty-four OA and 12 young adults (YA) were studied. OA was randomized to receive either GlyNAC (N = 12) or isonitrogenous alanine placebo (N = 12) for 16-weeks; YA (N = 12) received GlyNAC for 2-weeks. Participants were studied before, after 2-weeks, and after 16-weeks of supplementation to assess GSH concentrations, OxS, MFO, molecular regulators of energy metabolism, inflammation, endothelial function, IR, aging hallmarks, gait speed, muscle strength, 6-minute walk test, body composition, and blood pressure.

Results

Compared to YA, OA had GSH deficiency, OxS, mitochondrial dysfunction (with defective molecular regulation), inflammation, endothelial dysfunction, IR, multiple aging hallmarks, impaired physical function, increased waist circumference, and systolic blood pressure. GlyNAC (and not placebo) supplementation in OA improved/corrected these defects.

Conclusion

GlyNAC supplementation in OA for 16-weeks was safe and well-tolerated. By combining the benefits of glycine, NAC and GSH, GlyNAC is an effective nutritional supplement that improves and reverses multiple age-associated abnormalities to promote health in aging humans. Clinical Trials Registration Number: NCT01870193

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcysteineInsulin ResistanceHumansMiceAnimalsAgedGlycineHealth PromotionOxidative StressAgingGlutathioneDietary SupplementsInflammationMitochondria

Stichwörter der Autor:innen

Clinical trialsGlyNACMetabolismOxidative stressSuccessful aging

Substanzen

AcetylcysteineGlycineGlutathione

Autor:innen und Institutionen

  • Translational Metabolism Unit, Section of Endocrinology, Diabetes and Metabolism, Department of Medicine.
  • Baylor College of Medicine, Houston, TX, USA.
  • Department of Surgery.
  • Baylor-St. Luke's Medical Center.
  • USDA/ARS Children's Nutrition Research Center.
  • Institute of Clinical and Translational Research.

ORCID-Profile: Rajagopal V Sekhar

Förderung

  • NIA NIH HHS
  • National Institutes of Health
  • National Institute of Aging

Zitieren

APA

Kumar, P., Liu, C., Suliburk, J., Hsu, J. W., Muthupillai, R., Jahoor, F., Minard, C. G., Taffet, G. E., & Sekhar, R. V. (2023). Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. The Journals of Gerontology: Series A, 78(1), 75-89. https://doi.org/10.1093/gerona/glac135

Vancouver

Kumar P, Liu C, Suliburk J, Hsu JW, Muthupillai R, Jahoor F, et al. Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. The Journals of Gerontology: Series A. 2023;78(1):75-89. doi:10.1093/gerona/glac135

BibTeX
@article{Kumar2023,
  author = {Kumar, Premranjan and Liu, Chun and Suliburk, James and Hsu, Jean W and Muthupillai, Raja and Jahoor, Farook and Minard, Charles G and Taffet, George E and Sekhar, Rajagopal V},
  title = {Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial},
  journal = {The Journals of Gerontology: Series A},
  year = {2023},
  volume = {78},
  number = {1},
  pages = {75--89},
  doi = {10.1093/gerona/glac135}
}
Kostenlos starten →